The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600. (Q41698622)
Jump to navigation
Jump to search
scientific article published on 2 June 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600. |
scientific article published on 2 June 2015 |
Statements
1 reference
The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600. (English)
1 reference
D Massi
B Merelli
C Falcone
G Xue
A Carobbio
R Nassini
G Baroni
L Cattaneo
S Deaglio
2 June 2015
1 reference